Days after banning the use of Coldrif cough syrup across Punjab, the Directorate of Health and Family Welfare has now issued ...

The U.S. Food and Drug Administration recently approved Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) for ...

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination ...

Leqembi Iqlik, a subcutaneous formation of lecanemab, is now available as a maintenance dosing regimen for the treatment of early Alzheimer disease.

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner SQ Innovation Inc. has received approval from the U.S. Food and Drug Administration (FDA) for Lasix® ONYU ...

A new study argues that the IV hydration industry operates with almost no regulation and little medical evidence to support ...

IV hydration spas are popping up across the United States, offering pricey vitamin infusions that promise energy, detox or ...

Researchers sought to determine whether subcutaneous isatuximab would be an effective treatment for patients with RRMM.

New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who ...

Research study: Palatinus HN, Johnson MA, Wang HE, Hoareau GL, Youngquist ST. Early intramuscular adrenaline administration ...

The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option for patients. The subcutaneous form of Keytruda showed to deliver the same ...